Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parkin

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|July 20, 2007
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1Serge Dandache, Guy Sévigny, Jocelyn Yelle, et al.
Viruses|September 12, 2020
Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus CompoundsPhilip L Tzou, Kaiming Tao, Janin Nouhin, et al.
AIDS (London, England)|March 3, 2006
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessDavid R Bangsberg, Edward P Acosta, Reena Gupta, et al.
Scientific Reports|December 31, 2024
Characterisation of the optical response to seismic waves of submarine telecommunications cables with distributed and integrated fibre-optic sensingDavid M Fairweather, Max Tamussino, Ali Masoudi, et al.
AIDS Research and Human Retroviruses|October 11, 2008
Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibilityVinod Trivedi, Jana Von Lindern, Miguel Montes-Walters, et al.
Journal of Virology|February 26, 2005
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptaseLia van der Hoek, Nicole Back, Maarten F Jebbink, et al.
Viruses|May 31, 2020
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" SymposiumHezhao Ji, Paul Sandstrom, Roger Paredes, et al.
Journal of Virology|January 5, 2002
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 proteaseDeborah S Dauber, Rainer Ziermann, Neil Parkin, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Hepatitis C virus drug resistance-associated substitutions: State of the art summaryErik Lontok, Patrick Harrington, Anita Howe, et al.
AIDS Research and Human Retroviruses|July 23, 2009
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infantsJessica D Church, Wei Huang, Neil Parkin, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|July 20, 2007
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1Serge Dandache, Guy Sévigny, Jocelyn Yelle, et al.
Viruses|September 12, 2020
Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus CompoundsPhilip L Tzou, Kaiming Tao, Janin Nouhin, et al.
AIDS (London, England)|March 3, 2006
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessDavid R Bangsberg, Edward P Acosta, Reena Gupta, et al.
Scientific Reports|December 31, 2024
Characterisation of the optical response to seismic waves of submarine telecommunications cables with distributed and integrated fibre-optic sensingDavid M Fairweather, Max Tamussino, Ali Masoudi, et al.
AIDS Research and Human Retroviruses|October 11, 2008
Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibilityVinod Trivedi, Jana Von Lindern, Miguel Montes-Walters, et al.
Journal of Virology|February 26, 2005
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptaseLia van der Hoek, Nicole Back, Maarten F Jebbink, et al.
Viruses|May 31, 2020
Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" SymposiumHezhao Ji, Paul Sandstrom, Roger Paredes, et al.
Journal of Virology|January 5, 2002
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 proteaseDeborah S Dauber, Rainer Ziermann, Neil Parkin, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Hepatitis C virus drug resistance-associated substitutions: State of the art summaryErik Lontok, Patrick Harrington, Anita Howe, et al.
AIDS Research and Human Retroviruses|July 23, 2009
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infantsJessica D Church, Wei Huang, Neil Parkin, et al.
Pageof 7